Current Issue September 2010, Vol. 8, No. 9
Editor's Essential Reading
Editorial
- Benefit of Acid-Suppressive Therapy in Chronic Laryngitis: The Devil Is in the Details

Gastroesophageal reflux disease is increasingly associated with ear, nose, and throat symptoms. The surge of referrals for presumed reflux-related throat symptoms in a group of patients who are not responsive to aggressive acid suppression has resulted in frustration in the gastroenterology community. This is in no small part owing to poor diagnostic or treatment options for this group of patients.
Issue Highlights
Review
- Endoscopic Mucosal Resection in the Management of Esophageal Neoplasia: Current Status and Future Directions
Endoscopic mucosal resection has expanded the role of the gastroenterologist in the management of esophageal neoplasia from screening and diagnosis to staging and endoscopic treatment. Its rise to prominence is a reflection of the long-identified need to obtain histologic information regarding depth of invasion and neoplastic margins during therapy that previously could not be achieved with ablative techniques.
Endoscopy Corner
Low Incidence of Complications From Endoscopic Gastric Variceal Obturation With Butyl CyanoacrylateEndoscopic variceal obturation with tissue adhesive is used to control gastric variceal bleeding. We investigated the prevalence of serious complications from this therapy.
Brief Communication
Biofilm Demolition and Antibiotic Treatment to Eradicate Resistant Helicobacter pylori: A Clinical Trial Helicobacter pylori attaches to gastric mucosa and grows as a biofilm. This constitutes protection from antimicrobial agents. We assessed the role of a pretreatment with n-acetylcysteine in destroying biofilm and overcoming H pylori antibiotic resistance.
Original Articles—Alimentary Tract
- Rabeprazole Is Effective in Treating Laryngopharyngeal Reflux in a Randomized Placebo-Controlled Trial
There is controversy about the efficacy of treating patients with laryngopharyngeal reflux (LPR) using proton pump inhibitors (PPIs). We assessed the effects of high doses of the PPI rabeprazole in patients with LPR.
-
Skin Discoloration from Compulsive Bathing in a Patient with Hyperemesis Syndrome02 September 2010
-
A Splenic Artery Aneurysm that Mimics a Stromal Tumor and Causes Hematemesis02 September 2010
-
Do All Patients with Documented Infected Necrosis Require Necrosectomy/Drainage?02 September 2010
-
Fulminant Hepatic Failure Due to Amanita Phalloides Toxicity02 September 2010
-
Gastrointestinal bleeding from Brunner's gland hamartoma02 September 2010
-
Neither Long Term Statin Use Nor Atherosclerotic Disease Is Associated With Risk Of Colorectal Cancer02 September 2010
-
Norfloxacin Therapy for Hepatopulmonary Syndrome: A Pilot Randomized Controlled Trial02 September 2010
-
Exam 2: Incidence of Bleeding Following Invasive Procedures in Patients With Thrombocytopenia and Advanced Liver Disease26 August 2010
-
Exam 1: A 27-Year-Old Woman With Constipation: Diagnosis and Treatment26 August 2010
-
Low-Dose Maintenance Therapy With Infliximab Prevents Postsurgical Recurrence of Crohn's Disease23 August 2010


Podcasts
Risk and Reason in Barrett's Esophagus








